EOLS
Evolus Inc
8.00$
-3.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.5% | +19.7% | +3.4% | -1.8% | +1.3% | -8.3% | +7.2% | -4.3% | +3.1% | -2.3% | +12.4% | |
| – | +22.2% | +33.7% | +5.2% | -4.9% | +0.7% | -13.0% | +10.1% | -7.0% | +6.0% | -2.8% | +20.6% | |
| – | +62.4% | +54.3% | -3.4% | -9.2% | +2.3% | -21.9% | -9.1% | -29.5% | +23.7% | -7.5% | -9.3% | |
| – | +62.4% | +54.3% | -3.4% | -9.2% | +2.3% | -21.9% | -9.1% | -29.5% | +23.7% | -7.5% | -9.3% | |
| – | +0.2% | +12.2% | +26.0% | +3.5% | +6.8% | -0.5% | +0.5% | +5.7% | +8.5% | -4.5% | +19.5% | |
| – | -37.6% | +5.0% | +15.9% | +11.3% | -18.4% | -17.5% | +163.9% | +24.2% | -18.0% | -8.0% | +64.9% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +1.3% | -1.1% | -0.7% | +0.7% | +4.7% | +1.2% | 0.0% | -1.3% | -1.4% | -2.7% | -2.2% | |
| – | +11.9% | -0.9% | +3.2% | +4.3% | +1.5% | -3.1% | +12.5% | +0.1% | +0.5% | +0.2% | +11.8% | |
| – | -0.5% | -3.1% | +15.6% | +12.4% | +3.5% | -10.7% | +13.4% | +4.6% | +12.9% | -9.7% | +45.1% | |
| – | +1.0% | -16.3% | -9.6% | +53.8% | +7.3% | +14.5% | +21.6% | +3.5% | +2.1% | +0.9% | +0.9% | |
| – | -63.7% | +162.6% | -8.3% | +34.6% | -33.2% | +75.1% | +44.1% | -1.5% | +1.8% | -16.4% | +127.8% | |
| – | +26.6% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +19.4% | +0.2% | +0.2% | +7.1% | +0.2% | |
| – | – | – | +4.7% | -69.5% | -6.2% | -219.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.4% | +2.7% | +6.7% | +0.7% | +0.3% | +0.5% | +1.3% | +0.3% | -0.4% | +1.1% | +1.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.